A review of the landscape of targeted immunomodulatory therapies for non-infectious uveitis
Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This review aims to explore the current landscape of systemic uveitis treatments, including biologic therapies and the advent of biosimilar therapies.
Main Authors: | Sharma, S, Fu, D, Xue, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Healthcare
2017
|
Similar Items
-
Evolution of Diagnostic Methods for Infectious and Non-Infectious Uveitis. Review
by: E. V. Boyko, et al.
Published: (2022-07-01) -
Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study
by: Maria D. Pinazo-Durán, et al.
Published: (2021-04-01) -
Rituximab in the Treatment of Non-Infectious Uveitis: A Review
by: Cao H, et al.
Published: (2024-09-01) -
Review of the Effectiveness of Modern Treatment of Non-Infectious Uveitis
by: I. B. Medvedev, et al.
Published: (2023-07-01) -
High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis
by: Fleurieke H. Verhagen, et al.
Published: (2018-10-01)